Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers (Non-alcoholic Steatohepatitis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05441904
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Poxel SA 16
Early research (Phase 1)Study completedNCT03392779
What this trial is testing

Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 94
Testing effectiveness (Phase 2)Ended earlyNCT03329885
What this trial is testing

Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis

Who this might be right for
Rheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more
Bristol-Myers Squibb 38
Early research (Phase 1)UnknownNCT05063968
What this trial is testing

A Clinical Trial of XZP-6019 Tablets in Healthy Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xuanzhu Biopharmaceutical Co., Ltd. 120
Early research (Phase 1)Study completedNCT05053165
What this trial is testing

Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants

Who this might be right for
Rheumatoid ArthritisNon-Alcoholic Steatohepatitis
LISCure Biosciences 31
Early research (Phase 1)UnknownNCT05655221
What this trial is testing

A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis
Tasly Biopharmaceuticals Co., Ltd. 56
Early research (Phase 1)Study completedNCT04931147
What this trial is testing

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Who this might be right for
FibrosisInflammationIdiopathic Pulmonary Fibrosis+3 more
Redx Pharma Ltd 90
Early research (Phase 1)Looking for participantsNCT06216041
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Changchun Intellicrown Pharmaceutical Co. LTD 138
Early research (Phase 1)Study completedNCT02235233
What this trial is testing

Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin

Who this might be right for
Non-alcoholic Steatohepatitis
University of North Carolina, Chapel Hill 21
Early research (Phase 1)Looking for participantsNCT07099118
What this trial is testing

A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects

Who this might be right for
Non - Alcoholic Steatohepatitis
Sunshine Lake Pharma Co., Ltd. 96
Early research (Phase 1)Study completedNCT05766709
What this trial is testing

A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations

Who this might be right for
Non-alcoholic Steatohepatitis
Novo Nordisk A/S 53
Early research (Phase 1)Study completedNCT06365580
What this trial is testing

Dose Escalation Study of Kylo-0603 in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis
Kylonova (Xiamen) Biopharma co., LTD. 132
Early research (Phase 1)Study completedNCT04829123
What this trial is testing

The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects

Who this might be right for
Non-alcoholic Steatohepatitis
Dongguan HEC Biopharmaceutical R&D Co., Ltd. 64
Early research (Phase 1)Study completedNCT05012423
What this trial is testing

FTIH Study of ECC0509 in Healthy Volunteers

Who this might be right for
Nonalcoholic SteatohepatitisOsteoarthritis
Eccogene 89
Not applicableStudy completedNCT06047847
What this trial is testing

Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption

Who this might be right for
NAFLDMASLDMild Inflammatory Context
Valbiotis 10
Early research (Phase 1)Study completedNCT05107336
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 44
Early research (Phase 1)Study completedNCT03031119
What this trial is testing

Multiple Ascending Dose and DDI Study

Who this might be right for
Healthy Volunteers
Pfizer 62
Early research (Phase 1)Study completedNCT04091061
What this trial is testing

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Pfizer 24
Early research (Phase 1)Study completedNCT04463017
What this trial is testing

Ascending Dose Study of HU6 in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Rivus Pharmaceuticals, Inc. 64
Early research (Phase 1)Ended earlyNCT05604287
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects

Who this might be right for
Healthy Participants
IlDong Pharmaceutical Co Ltd 67
Next Page